Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$2.62
CAD
+0.00 (%)
Last updated: 2026-09-17
Get CRDL alerts:
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
+1.55%
1 Week
-17.09%
1 Month
+5.22%
YTD
+92.65%
Key Statistics
Market Cap
$316.13M
52W High
$3.23
52W Low
$1.23
P/E Ratio
-
50 Day MA
$2.21
200 Day MA
$1.72
Beta
0.61
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $2.64 | $2.67 | $2.60 | $2.64 | $2.64 | 221,614 |
| 9/16/2026 | $2.58 | $2.64 | $2.52 | $2.62 | $2.62 | 302,789 |
| 9/15/2026 | $2.75 | $2.75 | $2.54 | $2.58 | $2.58 | 166,747 |
| 9/14/2026 | $2.71 | $2.83 | $2.71 | $2.77 | $2.77 | 172,324 |
| 9/11/2026 | $2.82 | $2.87 | $2.70 | $2.75 | $2.75 | 255,673 |
| 9/10/2026 | $3.13 | $3.13 | $2.73 | $2.77 | $2.77 | 388,652 |
| 9/9/2026 | $3.04 | $3.23 | $3.04 | $3.16 | $3.16 | 440,150 |
| 9/8/2026 | $3.04 | $3.08 | $2.99 | $3.06 | $3.06 | 391,147 |
| 9/4/2026 | $2.98 | $3.07 | $2.93 | $3.05 | $3.05 | 185,500 |
| 9/3/2026 | $2.97 | $3.03 | $2.88 | $2.98 | $2.98 | 306,982 |
Analyst Price Targets
Based on analyst covering CRDL · as of Sep 17, 2026
Wall Street analysts forecast CRDL stock price to rise 129.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+129.0% Upside
Current Price
C$2.62
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
79.1%
Annualized
90-Day Vol
62.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$3.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.80 | C$2.13 – C$3.68 |
| 60 trading days | C$2.97 | C$2.02 – C$4.37 |
| 90 trading days | C$3.16 | C$1.97 – C$5.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.34
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GLO | Global Atomic Corp | $0.71 | +44.90% |
| DIAM | Star Diamond Corp | $0.03 | +25.00% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +14.29% |
| YRB | Yorbeau Resources Inc | $0.06 | +10.00% |
| COPR | Coppernico Metals Inc. | $0.44 | +8.64% |
| NFGC | New Found Gold Corp. | $2.42 | +7.56% |
| TELY | TelyRx Holdings Inc. | $2.25 | +7.14% |
| LABS | Medipharm Labs Corp | $0.07 | +7.14% |
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestWhat's Going On With Cardiol Therapeutics Inc Class A Stock Friday?
September 2026
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Monday?
- Why Cardiol Therapeutics Inc Class A stock surged yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
August 2026
- Why Cardiol Therapeutics Inc Class A stock is plummeting today
- Why Cardiol Therapeutics Inc Class A stock fell yesterday
- Why Cardiol Therapeutics Inc Class A stock surged yesterday
- Why Cardiol Therapeutics Inc Class A stock surged yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock is sliding today
- Why Cardiol Therapeutics Inc Class A stock went up yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Cardiol Therapeutics Inc Class A CRDL Earnings Beat Estimates by 50.0%